The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1101/mcs.a006120
|View full text |Cite
|
Sign up to set email alerts
|

PIK3CA mutation in a case of CTNNB1-mutant sinonasal glomangiopericytoma

Abstract: Glomangiopericytomas are rare, primary sinonasal tumors. The existing literature is mostly limited to reports describing the clinicopathologic characteristics of these tumors. Comprehensive genetic characterization of glomangiopericytomas remain lacking. Whole exome sequencing of a case of glomangiopericytoma was performed under an institutional review board approved protocol. A 69 year-old female underwent surgical resection of a glomangiopericytoma. Whole exome sequencing revealed somatic mutations in CTNNB1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 28 publications
(61 reference statements)
0
3
0
Order By: Relevance
“…Molecular testing for gene mutations in CTNNB1 and PIK3CA and gene fusions of PAX3::MAML3/NCOA1/FOXO1, NAB2::STAT6, and LMNA/TPM3/TPR::NTRK1 were performed using formalin-fixed, paraffin-embedded tumor tissue and the primers listed in Supplementary Table 1. Mutational analysis by Sanger sequencing detected a CTNNB1 S33A mutation (Figure 4); however, hot spot mutations in PIK3CA , which have been previously described in a case report of sinonasal glomangiopericytoma, 3 were negative. In addition, PAX3::MAML3 , PAX3::NCOA1, PAX3::FOXO1, NAB2::STAT6, LMNA::NTRK1, TPM3::NTRK1, and TPR::NTRK1 gene fusions investigated were not detected via reverse transcription-polymerase chain reaction.…”
Section: Case Reportmentioning
confidence: 76%
“…Molecular testing for gene mutations in CTNNB1 and PIK3CA and gene fusions of PAX3::MAML3/NCOA1/FOXO1, NAB2::STAT6, and LMNA/TPM3/TPR::NTRK1 were performed using formalin-fixed, paraffin-embedded tumor tissue and the primers listed in Supplementary Table 1. Mutational analysis by Sanger sequencing detected a CTNNB1 S33A mutation (Figure 4); however, hot spot mutations in PIK3CA , which have been previously described in a case report of sinonasal glomangiopericytoma, 3 were negative. In addition, PAX3::MAML3 , PAX3::NCOA1, PAX3::FOXO1, NAB2::STAT6, LMNA::NTRK1, TPM3::NTRK1, and TPR::NTRK1 gene fusions investigated were not detected via reverse transcription-polymerase chain reaction.…”
Section: Case Reportmentioning
confidence: 76%
“…There was only minimal mass effect, and no adjacent cerebral edema. Christopher S. Hong et al [ 26 ] CT/MRI CT: A hypodense, partially cystic mass in the right nasal cavity causing obstruction and opacification of the right posterior ethmoid air cells and sphenoid sinus, as well as bony remodeling of the ipsilateral cribriform plate and lateral lamella. MRI: Demonstrated a 3.3 × 1.2-cm enhancing soft tissue mass, protruding into the ipsilateral sphenoid sinus without definite intracranial extension.…”
Section: Discussionmentioning
confidence: 99%
“…Surgical resection is the primary treatment for GPC 1024,1028,1033 . In one systematic review, clean surgical margins resulted in 100% 5‐year survival with no evidence of recurrence or metastasis (10/10) 1022 .…”
Section: Other Rare Benign Neoplasms and Lesionsmentioning
confidence: 99%